Active Ingredient: OSIMERTINIB MESYLATE
Proprietary Name: TAGRISSO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 80MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208065
Product Number: 002
Approval Date: Nov 13, 2015
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Prescription
Patent and Exclusivity Information
